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Abstract
Firefighters are exposed to carcinogens and have elevated cancer rates. We hypothesized
that occupational exposures in firefighters would lead to DNA methylation changes associ-
ated with activation of cancer pathways and increased cancer risk. To address this hypothe-
sis, we collected peripheral blood samples from 45 incumbent and 41 new recruit non-
smoking male firefighters and analyzed the samples for DNA methylation using an Illumina
Methylation EPIC 850k chip. Adjusting for age and ethnicity, we performed: 1) genome-wide
differential methylation analysis; 2) genome-wide prediction for firefighter status (incumbent
or new recruit) and years of service; and 3) Ingenuity Pathway Analysis (IPA). Four CpGs,
including three in the YIPF6, MPST, and PCED1B genes, demonstrated above 1.5-fold sta-
tistically significant differential methylation after Bonferroni correction. Genome-wide meth-
ylation predicted with high accuracy incumbent and new recruit status as well as years of
service among incumbent firefighters. Using IPA, the top pathways with more than 5 gene
members annotated from differentially methylated probes included Sirtuin signaling path-
way, p53 signaling, and 5’ AMP-activated protein kinase (AMPK) signaling. These DNA
methylation findings suggest potential cellular mechanisms associated with increased can-
cer risk in firefighters.
Introduction
Epidemiologic studies of firefighters from multiple countries have demonstrated an elevated
rate of cancer incidence and/or mortality for a number of cancer types [1–8]. For example, in a
recent study of three large fire departments in the United States, overall cancer incidence
and mortality was significantly increased by 9% and 14%, respectively, as compared with the
general population, and significant increases in cancer incidence and mortality were noted
specifically for cancers of the esophagus, intestine, lung, and kidney [2]. Firefighters are
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occupationally exposed to multiple products of combustion and other substances containing
carcinogens through inhalation and/or skin contamination [9–11], including but not limited
to polycyclic aromatic hydrocarbons (PAHs), benzene, per- and polyfluoroalkyl substances
(PFAS) and diesel exhaust [11–15]. However, other risk factors such as shift work may also
contribute to this elevated cancer risk [16].
Epigenetic modifications are critical steps in carcinogenesis and cancer prevention [17, 18].
We have previously shown that microRNAs are differentially expressed between incumbent
and new recruit firefighters [19], but published information on DNA methylation in firefight-
ers to our knowledge has been limited to four genes [20]. DNA methylation refers to the addi-
tion of a methyl group to cytosine within 5’-C-phosphate-G-3’ (CpG) dinucleotides, which are
often concentrated in large clusters called CpG islands. Inactivation of certain tumor-suppres-
sor genes occurs as a consequence of hypermethylation within the promoter regions and
numerous studies have demonstrated a broad range of genes silenced by DNA methylation in
different cancer types [21–24]. Global hypomethylation, inducing genomic instability, also
contributes to cell transformation. Apart from DNA methylation alterations in promoter
regions and repetitive DNA sequences, this phenomenon is associated with regulation of
expression of noncoding RNAs such as microRNAs that may play a role in tumor suppression.
Furthermore, DNA methylation has shown promise in putative translational use in patients
and hypermethylated promoters may serve as disease-related biomarkers [25, 26]. Importantly,
while every effort is made by previous studies to put identified methylation signatures in con-
text, it should be noted that the landscape of methylation alterations and the associated impact
on gene activity is extremely complex. Thus, changes in methylation signatures are not always
clearly linked to specific alterations in gene activity.
We hypothesized that compared to new recruits without previous firefighting experience,
incumbent firefighters would show differential DNA methylation patterns that had been previ-
ously associated with cancer. We analyzed DNA methylation in peripheral blood by microar-
ray and compared the results between new recruits and incumbent firefighters to address this
hypothesis.
Methods
Subjects
Study protocols were approved by the University of Arizona Institutional Review Board
(approval No.1509137073) and all subjects provided written informed consent. The study sub-
jects were selected from a larger group of incumbent firefighters within the Tucson Fire
Department (Tucson, Arizona, United States of America) and new recruit firefighters prior to
any live-fire exposures or other occupational exposures to fire and smoke. All subjects com-
pleted questionnaires regarding their age, body weight, height, working duration as firefight-
ers, and tobacco use.
Initially, blood for methylation analysis was collected from 47 male incumbents and 48
male and one female new recruits. Subjects who either had current smoking exposure or miss-
ing smoking information and the sole female recruit were excluded, leaving 86 (45 incumbents
and 41 recruits) subjects for methylation data analysis. Body mass index (BMI) (kg/m2) was
classified as normal (18.5–24.9), overweight (25.0–29.9), and obese (� 30) following World
Health Organization (WHO) classifications.
DNA methylation measurement
Blood samples were collected in one 6.0 ml dipotassium ethylenediaminetetraacetic acid
(K2EDTA) tube (Becton, Dickinson and Company, Franklin Lakes, NJ) for DNA methylation
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analyses. As an alternative to the ethylenediaminetetraacetic acid (EDTA) tube, eight samples
were also collected in cell preparation tubes (CPTs) (Becton, Dickinson and Company, Frank-
lin Lakes, NJ). The EDTA tube was processed within 30 minutes of collection, which consisted
of centrifugation at 3200 rpm for 15 minutes and separation of the plasma from the cells. All
aliquots were stored at -20 ˚C until transfer under Arizona Department of Transportation
guidelines to the University of Arizona for storage at -80 ˚C for subsequent processing by the
University of Arizona Genetics Core. The CPT was processed according to the product guide-
lines and the cell pellet was stored at -80 ˚C until processed.
Genomic DNA from the EDTA tubes and CPTs was isolated using the FlexiGene DNA
Kit (Qiagen, Valencia, CA). Genomic DNA was extracted from 9 additional packed cell pel-
lets from CPTs using the Qiagen DNeasy Blood and Tissue Kit. DNA quantity was assessed
with the QuantiFluor dsDNA System (Promega, Madison, WI) on the Synergy HT plate
reader (BioTek Instruments, Inc., Winooski, VT) and 96 of the highest yield samples were
normalized to 250ng in 30uL. The samples then underwent bisulfite conversion using the
Zymo EZ DNA Methylation Kit (Zymo Research Corp., Irvine, CA) with a genomic DNA
input of 250ng. The recommended modification to the protocol using alternative incuba-
tion conditions for the Illumina assays was performed. Upon bisulfite conversion comple-
tion, samples were sent to the University of Utah DNA Sequencing and Genomics Core
Facility (Salt Lake City, Utah) for Infinium HD Methylation using the Illumina Methylatio-
nEPIC kit (Illumina, Inc., San Diego, CA) scanning on the iScan instrument, and raw data
export.
Raw intensity data were processed by Bioconductor package minfi (version 1.22.1) [27]
which included normalization of data using Illumina’s reference factor-based normalization
methods (preprocess Illumina) and Subset-quantile Within-Array Normalisation (SWAN)
[28] for type I and II probe bias correction. All samples passed quality control. A detection p-
value is returned for every genomic position in every sample, with small p-values indicating
good quality probes. Probes with detection p-value > 0.05 in one or more samples, and probes
with single-nucleotide polymorphisms (SNPs) inside their body or at the nucleotide extension
were excluded, leaving 834,912 probes. DNA methylation levels (M-values) were determined
by calculating the logarithm of the ratio of intensities between methylated (signal A) and
unmethylated (signal B) alleles, log (A/B) [28, 29]. Potential batch effects were investigated
using principal component analysis using M-values.
Statistical analyses
Differential methylation analysis. Differentially methylated probes were detected using
the limma package [30]. A linear model with Empirical Bayes estimator was adopted [31], with
adjustment for age, ethnicity, and BMI. Probes were considered to be differentially methylated
if the resulting adjusted p-value was <0.05. The Bonferroni correction method was used to
adjust the p-values and ensure that the familywise error rate was less than 0.05 [32]. The
DMRcate package was used to identify differentially methylated regions (DMR) based on tun-
able kernel smoothing of the differential methylation signal, adopting the default setting [33].
DMRcate uses limma-derived statistics for calculation of individual CpG site methylation dif-
ferences and it can assess all 850K probes as candidates for DMR constituents. The corre-
sponding gene list was derived from the gene annotations associated with the probes. Because
our DNA samples were derived from blood, we estimated white blood cell type composition
for every individual using the Houseman method [34]. We corrected the analysis by including
the estimated cell type composition as covariates in the linear model. Only results that were
significant first without and then also with adjustment for cell type composition were reported
DNA methylation among firefighters
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as it has been shown that when cell composition and age are confounded, adjustment of cell-
type composition can lead to false positives [35].
Genome-wide methylation prediction. Genome-wide methylation prediction was per-
formed with the glmnet package using elastic-net penalization [36]. Years of service informa-
tion was collected for both incumbent and new recruit firefighters. Since the newly recruited
firefighters’ years of service measures were zero, we carried out a two-stage prediction model
to incorporate this excess of zeros in the distribution of years of service. In the first stage we
used genome wide methylation profile, age, BMI, and ethnicity to predict job status, i.e.,
recruit vs incumbent firefighter, which is equivalent to exposed to fire or not. In the second
stage, for firefighters predicted to be incumbents, we then predicted their years of service. We
employed a 10-fold cross validation strategy to repeatedly perform trainings on 90% of our
sample set while holding out 10% of the samples for a test set. This procedure was repeated 10
times on unique subgroups of the entire data set.
Pathway analysis. We performed pathway analysis for the top probes differentially meth-
ylated between new recruits and incumbent firefighters using a p value of< 10−4 selected
based on the published literature [37], and an empirically selected 1.5-fold change between the
two groups. These probes were annotated to genes according to the closest transcription start
site (TSS) [38]. The gene list was uploaded to QIAGEN Ingenuity Pathway Analysis (IPA,
QIAGEN Redwood City) for assessing overrepresentation relative to all human gene functions
[39]. The Pathway Build and Relationship Summary tools in IPA were used to build the gene
regulatory networks, including expression regulation, protein-protein/DNA interaction, acti-
vation and inhibition. Genes were ranked by their connectivity in the regulatory networks,
and genes with the top 10% connectivity were chosen as hubs. Hub genes play important roles
in gene regulation due to their multiple interactions with other genes [40]. Two analyses were
then performed to reveal the related canonical pathways and human diseases. First, using the
Canonical Pathways tool, we identified canonical signaling (or metabolic) pathways with asso-
ciated input genes and ranked the pathways by the number of gene members. Pathways that
included more than five gene members were defined as top canonical pathways in this regula-
tory network. Second, using the IPA scientific literature-based Diseases and Functions overlay
tool we annotated the genes enriched within human diseases and biological functions. The
software is backed by highly structured, detail-rich biological and chemical findings derived
from top journals and reviewed using full text and is also supported by third-party informa-
tion, including but not limited to GO, TarBase, ClinicalTrials.gov, and BIND. It retrieves a
wealth of experimental evidence for genes and explores the association with diseases or pheno-
types by leveraging the depth of the Ingenuity Ontology and the Human Phenotype Ontology.
With the IPA application, the significance of each enriched disease module is calculated as fol-
lows: (1) the number of input genes mapped to a given disease module in the IPA literature
database, denoted by m; (2) the number of genes included in the disease module, denoted by
M; (3) the total number of input genes mapped to the IPA’s literature database, denoted by n;
and (4) the total number of known genes included in the IPA’s literature database denoted by
N. The significance of gene enrichment in the disease module is then calculated using a one-
tailed Fisher’s exact test [41]. Genes with no regulatory relationship with any other genes were
excluded from analysis.
As IPA does not take the direction of the effects into consideration, directionality of meth-
ylation alteration was not assessed separately. Instead all alterations (whether gain of methyla-
tion or loss of methylation) were included in the analysis. The rational for this approach is that
the methylation signature and associated alterations are a reflection of a cell’s transcriptional
activity. Thus, regardless of direction, all methylation states in our samples of interest in theory
contribute to the activity of cellular pathways.
DNA methylation among firefighters
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Results
Subjects
All subjects were white, and a similar percentage of incumbent and new recruit firefighters
were of Hispanic ethnicity (Table 1). The subjects’ mean age in years was significantly higher
in incumbents (40.6 ± 7.7) than in recruits (28.9 ± 6.3) (p<0.001). The incumbent firefighters
and recruits had similar distribution of BMI. For incumbents, the mean number of years serv-
ing as a firefighter was 14.0 ± 7.2 years, and number of years of service was significantly corre-
lated with age (Pearson’s r = 0.804, p<0.0001). Distribution of cell type composition across job
status is shown in Fig 1. There were no significant differences comparing the incumbent and
new recruit firefighters.
Differential methylation analysis
Comparing incumbents to recruits and adjusting for multiple comparisons, age, BMI, and
ethnicity, as well as cell type composition, four CpGs (cg00287370, cg05236728, cg12253469
and cg24034992) demonstrated statistically significant differential methylation exceeding
1.5-fold (Table 2). These four CpGs included one that was hypermethylated and three that
were hypomethylated in incumbent firefighters compared to new recruits. Two of the three
hypomethylated CpGs were annotated to promoter regions. One additional CpG
(cg07897354) demonstrated significantly reduced methylation in incumbents as compared
with recruits when adjusting for multiple comparisons, age and ethnicity, but lost signifi-
cance when BMI was added to the model. In order to further assess the effects of age on dif-
ferential methylation between incumbent and new recruit firefighters, we also investigated
whether any of the CpG sites in Table 2 varied significantly by age group (<40 years old
vs > 40 years old). None of these sites was significantly associated with age after correction
for multiple comparisons (data not shown). In a separate analysis, 41 differentially methyl-
ated regions were identified, of which seven were still significant after adjustment for cell
type compositions (Table 3).
Genome-wide methylation prediction
Using a 10-fold cross validation procedure, we applied machine learning algorithms to deter-
mine which CpGs had variable methylation associated with firefighters’ service status, i.e.,
new recruit or incumbent, and the years of service each individual had performed. In each
stage of cross validation, the CpGs that were determined by the training to be predictive
were noted. A total of 91 CpGs were selected at least once during the 10 rounds of training
associated with firefighters’ years of service. However, only 11 CpGs (cg09544149,
cg24034992, cg22280238, cg00287370, cg02932780, cg13753209, cg15304928, cg07897354,
cg22433210, cg20821958, and cg03177084) were selected in more than half of the trainings.
The best-performing model was chosen based on the lowest misclassification rate in the first
stage and the lowest mean squared error of years of service in the second stage in the test set.
This model was then applied to the entire data set and predictions were compared to the
actual years of service (Fig 2). The resulting misclassification rate between predicted incum-
bents and actual incumbent firefighters was 2% in the first stage and within incumbent fire-
fighters the correlation of predicted and actual years of service was robust with an R2 of
0.889. We also evaluated whether including DNA methylation could increase predictive
power compared to only using the covariates age, BMI, and ethnicity. By adding methylation
levels to the prediction model, r2 increased from 0.533 to 0.889 and the misclassification rate
was reduced from 8% to 2% (data not shown).
DNA methylation among firefighters
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Pathway analysis
Five hundred and twelve CpG sites demonstrated differential methylation with a p-value< 10−4
and at least 1.5-fold differences between incumbent firefighters and new recruits. They were
annotated to 443 unique genes which were used to build a gene regulatory network (Fig 3).
There were 93 genes that had at least one connection with other genes in the regulatory net-
work. All hub genes had at least 20 connected relationships. They included STAT3, TP63,
TP73, FOXO1, PML, DAXX, RUNX2, INSR, and PCNA. Top pathways with more than 5 gene
members annotated from differentially methylated probes included the Sirtuin signaling path-
way (3 hubs of 8 gene members: FOXO1, STAT3 and TP73), molecular mechanisms of cancer
(2 hubs of 7 gene members: DAXX and FOXO1), p53 signaling (4 hubs of 7 gene members:
PCNA, PML, TP63 and TP73), and 5’ AMP-activated protein kinase (AMPK) signaling (2
hubs of 6 gene members: FOXO1 and INSR). Enriched diseases (disease annotation) included
abdominal cancer (9 hubs of 88 genes), colon tumor (8 hubs of 44 genes), skin cancer (6 hubs
of 51 genes), and lung tumor/cancer (5 hubs of 49 genes), all with p-values <10−6 in IPA
(Table 4). To address the effect of using a different fold change criteria, we performed a sensi-
tivity analysis by using the same p-value < 10−4 but with a two-fold change limit (data not
shown). The sensitivity analysis identified 293 CpG sites annotated to 282 unique genes
(reduced from 512 CpG sites annotated to 443 genes in the primary analysis). Among them,
67 genes had at least one connection with other genes in the regulatory network based on IPA
databases. Using the same hub gene criterion as in the primary analysis (i.e., with>20 connec-
tions with other genes in the regulatory network), six hub genes were identified, including
STAT3, PML, RUNX2, DAXX, PCNA, and INSR. All of them were also reported in the primary
analysis. The Sirtuin signaling pathway remained the top pathway with 5 annotated gene
members, and the molecular mechanisms of cancer, p53 signaling, and AMPK signaling path-
ways all had at least 3 gene members.
Discussion
The results of this study support our hypothesis that, compared to new recruits, incumbent
firefighters would show differential DNA methylation associated with cancer pathways. This
Table 1. General characteristics of subjects.
Variable Recruits (n = 41) Incumbents (n = 45) P-value
Age (years)
� 29 23 (56.1%) 3 (6.67%) <0.0001
30–39 14 (34.1%) 15 (33.3%)
� 40 4 (9.76%) 27 (60.0%)
Mean (SD) 28.9 (6.3) 40.6 (7.7) <0.0001
Body Mass Index (kg/m2)
Normal (18.5–24.9) 13 (31.7%) 9 (20.0%) 0.39
Overweight (25.0–29.9) 22 (53.7%) 26 (57.8%)
Obese (� 30) 6 (14.6%) 10 (22.2%)
Race/Ethnicity
White, Hispanic 6 (14.6%) 6 (13.3%) 1.0
White, Non-Hispanic 35 (85.4%) 39 (86.7%)
Years of Service
Mean (SD) 0.85 (1.5) 14.0 (7.2) < 0.0001
Missing 0 1 (2.2%)
https://doi.org/10.1371/journal.pone.0214282.t001
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Fig 1. Cell type proportion among new recruit and incumbent firefighters.
https://doi.org/10.1371/journal.pone.0214282.g001
Table 2. Differentially methylated positions.
CpG Recruitsa Incumbenta FCb 95% CI Chr UCSC RefGene Name CpG Site Location Regulatory Feature Group
Lower Upper
cg12253469 98.7% (0.4%) 99.1% (0.3%) 2.40 1.81 3.20 22 MPST Gene Body
cg00287370 5.5% (0.9%) 3.7% (0.8%) 0.49 0.40 0.60 1 Promoter Associated
cg24034992 8.4% (1.3%) 5.2% (1.7%) 0.43 0.34 0.55 X YIPF6 Gene Body Promoter Associated Cell type specific
cg05236728 3.1% (0.9%) 2.0% (0.8%) 0.40 0.34 0.55 12 PCED1B Gene Body; 5’UTR
cg07897354c 4.4% (1.2%) 2.7% (0.9%) 0.44 0.34 0.58 18 SPIRE1 Promoter Associated
aGroup mean (SD) of % methylation (Beta values).
bFold changes (FC) of M values of CpG sites in incumbents compared to recruits with adjustment for age, ethnicity, and body mass index (BMI).
cFold changes shown with adjustment for age and ethnicity; statistical significance lost when also adjusting for BMI.
https://doi.org/10.1371/journal.pone.0214282.t002
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adds to the currently sparse body of literature describing the epigenetic effects among firefight-
ers, a population occupationally exposed to known carcinogens with documented increased
cancer risk [2].
Our differential methylation analysis identified five CpGs assigned to both promoter and
non-promoter regions. Promoter hypermethylation frequently leads to silencing of tumor-
suppressor or DNA repair genes in cancers while hypomethylation of CpGs often results in
overexpression of genes [22, 42–44]. However, recent investigations of broader methylation
patterns suggest that non-promoter (intragenic) methylation may also affect transcription reg-
ulation and efficiency; while CpG hypermethylation in non-promoter regions does not impede
transcription (as it does in promoter regions), it has been correlated with increased or ectopic
gene expression [45–48].
Four of the five differentially expressed CpG sites are located in genes with known functions
and reported associations with cancer and metastatic potential. However, all five differentially
expressed CpGs identified in this study represent novel epigenetic markers that have not previ-
ously been reported in the limited body of literature describing differential DNA methylation
in firefighters or those with similar occupational exposures. One CpG with decreased methyla-
tion among incumbent firefighters was located on the YIPF6 gene, annotated to the promoter
region. YIPF6 has been associated with prostate cancer, and amplification and overexpression
of YIPF6 protein has been posited to indirectly stimulate tumor progression [49, 50]. Another
CpG with decreased methylation in incumbent firefighters is located in the gene body of
PCED1B. This gene encodes a protein that belongs to the GDSL/SGNH-like acyl-esterase fam-
ily, hydrolases thought to function in modification of biopolymers on the cell surface. High
expression of this gene has significant associations with renal (unfavorable) and urothelial can-
cer (favorable) patient survival based on Cancer Genome Atlas (TCGA) data (https://www.
proteinatlas.org/ENSG00000179715-PCED1B/pathology). One CpG with decreased methyla-
tion in incumbent firefighters, that was statistically significant until additionally adjusted for
BMI (Table 2), is located in the promoter region of SPIRE1. The dysregulated expression of the
protein encoded by this gene, SPIRE1, has been associated with cellular potential for extracel-
lular matrix degradation, which may impact the invasive and metastatic behavior of cancer
cells [51]. The hypermethylated CpG identified in our analysis was located on the MPST gene
body. The MPST encoded protein is associated with cysteine degradation, cyanide detoxifica-
tion and likely other metabolic processes, given observed MPST deficiency in individuals with
the heritable disorder, mercaptolactate-cysteine disulfiduria [52]. As part of its cysteine degra-
dation pathway, MPST produces enzymes involved in formation of sulfane sulfur containing
compounds. Sulfur metabolism dysregulation in cancer cells and anti-cancer effects in vivo of
Table 3. Differentially methylated regions.
Coordinate Number of CpGs within region Mean Beta FC within regiona
chr19:37825009–37826008 12 0.07292553
chr19:52390810–52392100 15 0.05981331
chr12:47219626–47220197 13 0.08163149
chr19:12305392–12306303 10 0.03812897
chr15:29562049–29562633 10 -0.0089748
chrX:67719027–67719066 2 -0.0178829
chr14:64108940–64109325 5 -0.0089722
aFold change comparing incumbents to new recruits after adjustment for age, body mass index (BMI), ethnicity and
cell type composition.
https://doi.org/10.1371/journal.pone.0214282.t003
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sulfane sulfur precursors suggest that proliferation of malignant cells may be related to a defi-
ciency of sulfane sulfur and the uncontrolled operation of a set of enzymes normally inacti-
vated by sulfane sulfur [53].
Of the seven differentially methylated regions that remained significant after correction for
cell type composition, three were located on genes (SYNE2, AR, and PCED1B) with known
functions and disease associations. SYNE2 encodes a protein involved in maintaining the
structural integrity of the nucleus. AR, the androgen receptor gene, encodes a member of the
steroid hormone nuclear receptor family that regulates gene expression. AR signaling is
reported to be involved in prostate, bladder, liver, kidney and lung tumorigenesis and metasta-
sis [54, 55]. Differential methylation patterns of AR are also associated with prostate cancer,
Fig 2. Predictive model for ‘years of service’ based on CpG level DNA methylation signals (n = 91).
https://doi.org/10.1371/journal.pone.0214282.g002
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Fig 3. The gene regulatory network and pathways of enriched differential probes between new recruit and incumbent firefighters. Hub
genes are highlighted in green. Top background and canonical pathways are highlighted in yellow. Connections between hub genes and top
pathways are marked with blue lines.
https://doi.org/10.1371/journal.pone.0214282.g003
Table 4. Disease annotation, number of related genes, and the corresponding hubs.
Disease annotation p-value # of genes Hub genes
Abdominal cancer 5.1e-18 88 STAT3, TP63, TP73, FOXO1, PML, DAXX, RUNX2, INSR, PCNA
Abdominal neoplasm 2.2e-19
Abdominal carcinoma 1.1e-11
Adenocarcinoma 5.4e-16
Colon tumor 5.9e-09 44 STAT3, TP63, TP73, FOXO1, DAXX, RUNX2, INSR, PCNA
Skin cancer 2.9e-07 51 STAT3, TP63, PML, DAXX, RUNX2, INSR
Lung tumor 6.6e-07 49 INSR, PCNA, STAT3, TP63, TP73
Lung cancer 1.0e-06
https://doi.org/10.1371/journal.pone.0214282.t004
DNA methylation among firefighters
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non-Hodgkin’s lymphoma, and ovarian cancer [24, 56–58]. Variants of SYNE2 have been asso-
ciated with p21 expression and reduced overall survival in hepatitis B-related hepatocellular
carcinoma [59]. p21 is a cell cycle regulator reported to downregulate TP53, a tumor suppres-
sor [60, 61]. Known functions of PCED1B, which also contained a differentially methylated
CpG as shown in Table 2, were previously discussed above. Information for the four remaining
regions were sparse. One region was located on the protein coding gene FAM189A1, which is
reported to have tissue-specific expression in brain and colon, but no known disease associa-
tions [62]. No information about function or disease associations was found for ZNF528-AS1.
One region was located on or near uncharacterized genes (AC016582.2 and CTD-2554C21.2)
and for the region containing chr19:12,305,392–12,306,303 no further information was
available.
Because DNA methylation signatures are tightly correlated to transcriptional activity
throughout the genome, they provide a powerful platform for prediction of complex traits or
diseases [63–65]. Our machine learning analyses were used to predict whether or not an indi-
vidual was an incumbent firefighter (and had thus had a certain anticipated level of environ-
mental exposures) and how long that individual had been in the service. Five of the 11 CpGs
identified in our best-performing predictive model, cg24034992, cg02932780, cg15304928,
cg07897354, and cg03177084, were located on or near genes YIPF6, VARS, TMEM9, SPIRE1,
and PSME3, respectively. YIPF6, TMEM9, and PSME3 have been associated with cancer [49,
50, 66–69] and SPIRE1 reportedly contributes to metastatic potential [51]. VARS encodes a
multi-domain protein that catalyzes the aminoacylation of tRNA and has been associated with
neurodevelopmental disorders [70]. No information was available for the remaining 6 CpGs.
The top identified canonical pathways with differentiated methylated genes included many
associated with cancer. The sirtuins, which regulate a large number of cellular pathways and
protect the age-associated diseases, regulate processes in cancer cells such as DNA repair and
cancer metabolism [71, 72]. More than half of all cancers may involve p53-inactivating muta-
tions, and downstream p53 signals result in cell cycle arrest, apoptosis or senescence [72–74].
AMPK, a highly conserved kinase through evolution, regulates energy-consuming biosynthetic
pathways, and activation of AMPK by pharmacological or other means might reduce cancer
incidence [75, 76]. The STAT3 gene, the top identified hub, is a component of essential chemi-
cal signaling pathways within cells and an ideal target for chemoprevention and cancer therapy
[77, 78]. STAT3 acetylation silences gene expression and enhances DNA methylation of key
tumor-suppressor gene promoters, and inhibition of STAT3 acetylation reverses aberrant CpG
island methylation and leads to the reactivation of several tumor-suppressing gene promoters
[79]. Overexpression of STAT3 leads to continued growth of tumor cells and promotes other
malignant properties such as tumor angiogenesis [80, 81]. Tumor proteins p63 and p73,
encoded by the TP63 (on p53 pathway) and TP73 genes (on both p53 and Sirtuin pathway),
provide a complex contribution to tumorigenesis as they regulate cell cycle and apoptosis after
DNA damage. For example, TP73 has been found to be transcriptionally silenced in lympho-
blastic leukemias and lymphomas induced by CpG island methylation [82–84]. p63 genomic
amplification may have an early role in lung tumorigenesis and may act as a biomarker for
lung cancer progression [84]. INSR, has been used as a biomarker for prognosis of non-small
cell lung cancer and an INSR protein inhibitor, Zykadia, has been authorized by U.S. Food
and Drug Administration (FDA) [85] and European Medicines Agency [86] as a treatment of
advanced ALK-positive non-small cell lung cancer [87].
Increased risk of many of the enriched diseases identified in our pathway analysis (abdomi-
nal cancer, adenocarcinoma, colon tumor, skin cancer, lung cancer) have been previously
reported among firefighters. A study examining firefighters from Nordic countries reported
excess risk of adenocarcinomas among firefighters aged 70 years and older [6]. In a pooled
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cohort of US firefighters, excess cancer mortality and incidence were reported for digestive
and respiratory sites, including colorectal, mesothelioma and lung cancers [2]. A higher risk of
colorectal cancer was also observed in a 2006 meta-analysis of 32 studies on firefighters [5].
Several studies have also reported higher prevalence and risk of non-melanoma and melanoma
skin cancer among firefighters [5–7, 88].
Firefighters are exposed to elevated concentrations of multiple products of combustion and
other toxic substances, including PAHs, benzene, and PFAS, many of which are carcinogenic,
genotoxic or mutagenic [11, 13, 89–92]. Studies among other highly exposed populations have
reported associations between PAH exposure and global or gene promoter-specific DNA
methylation changes, suggesting that these epigenetic changes may reflect a history of exposure
to PAHs [93, 94]. Firefighters also generally work in shifts, typically 24 hours, and shiftwork
that disrupts circadian rhythms has been concluded to be “probably carcinogenic” [16]. Stud-
ies in non-firefighter populations have also found that long-term shiftwork is associated with
differential DNA methylation and whole-genome methylation [95, 96] and there is increasing
evidence that long-term shiftwork may increase the risk of breast cancer via epigenetic mecha-
nisms [96–98]. Additional studies are needed, ideally prospective cohort studies with a larger
number of firefighters, to help validate the specific CpG sites identified in the current study
and to determine which exposures are associated with altered methylation at those sites.
Prior published studies on the relationship between firefighter occupational exposures and
epigenetic changes are scarce. We could find only one other study focused on differential
DNA methylation among firefighters. This study assessed promoter methylation in four a pri-
ori genes comparing firefighters to non-firefighting controls and reported significant
decreased methylation for one of the four genes, DUSP22, as well as a correlation between
duration of firefighting service and decreased methylation [20]. However, in our analysis we
were unable to detect significant differential DNA methylation at the DUSP22 promoter
region. Additionally, the previous study demonstrated that the decreased DUSP22 promoter
methylation was inducible in cultured human cells by low-dose exposure of benzo[a]pyrene, a
highly carcinogenic PAH [20]. In our previous analysis based on many of the same Arizona
firefighters evaluated in the current study, we identified nine miRNA markers differentially
expressed in incumbent firefighters compared to new recruits [19]. Notably, the six miRNAs
with reduced expression in incumbent firefighters have reported tumor suppressor activities
while two of the three miRNAs with increased expression are reported to participate in cancer
promoting activities, consistent with the hypothesis that firefighters are at increased cancer
risk.
The results of our study provide potential mechanisms linking firefighter exposures and the
excess risks of specific cancer types identified in epidemiologic studies of cancer in the fire ser-
vice [1–8]. Given the long latency between exposures and the development of cancer, ranging
from less than 5 years to greater than 30 depending on the type of cancer, DNA methylation
biomarkers have the potential to be used to both identify the cumulative effect of exposures
and to identify firefighters at increased risk of disease susceptibility. In addition to its use in
helping to predict future disease, DNA methylation could potentially be used to assist in deter-
mining cancer diagnosis and prognosis, as has been demonstrated in groups other than fire-
fighters [99–101]. For example, the methylation signature identified can be used as an
“epigenetic clock” of firefighting. If the magnitude and/or length of exposures is both predic-
tive of cancer risk and detectable in methylation signatures, it is likely that prediction of future
cancer risk may eventually be attainable. If this is true, it is possible that preventative efforts
and close monitoring can be put in place for firefighters at particularly high risk. Identification
of epigenetic markers both associated with exposures in firefighters and diseases also have the
potential to assist in determining occupational causation in workers’ compensation cases.
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Limitations of the current study include a relatively small sample size, a cross-sectional
design, and inclusion of firefighters from a single geographic region. There was also a signifi-
cant age difference between the incumbent and new recruit firefighters, although we adjusted
for age in our analyses. To further ensure that age differences were not driving the differential
methylation identified in our study, we assessed the CpGs known to be altered with age and
compared them to the CpGs identified in our study. We did not identify any overlap in these
significant regions (data not shown). Future longitudinal studies of a larger number of fire-
fighters across geographic regions are needed to determine the extent to which the findings
can be generalized to other firefighter populations, ideally with an external comparison group
of similar age to the incumbent firefighters. Information on lifestyle exposures was limited to
smoking; no information on diet was available, and occupational history was limited to years
as a firefighter. It will also be important in future studies to determine the association among
this broader group of exposures with the identified DNA methylation markers, as well as to
determine whether the markers are predictive of disease outcomes in firefighters.
Conclusions
In conclusion, DNA methylation varied among male non-smoking incumbent firefighters and
new recruits after adjusting for age, BMI and ethnicity. Furthermore, DNA methylation mark-
ers were also able to predict with high accuracy the number of years worked as a firefighter.
Based on pathway analysis, many of the DNA methylation markers were associated with can-
cer, supporting the potential for these changes to help explain the mechanism for increased
cancer risk among firefighters.
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